Skip to content
Back to LIF

Life360, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
68
Purchases
0
Sales
68
Purchase value
$0.00
Sale value
$76.63M

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Charles J. ProberDirector
4Rule 10b5-1 plan disclosed
Filed Nov 17, 2026Period of report Nov 13, 20260001581760-26-000187
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 13, 2026
Common stockF1F27,930$43.70$346.54K109,930Direct
Filing footnotes · 3
  1. F1The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
  2. F2Includes 3,361 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  3. F3The stock option is fully vested and exercisable.
Open on SEC EDGAR
John Philip CoghlanDirector
4Rule 10b5-1 plan disclosed
Filed Nov 4, 2026Period of report Nov 2, 20260001581760-26-000175
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 2, 2026
Common stockF1F21,841$45.29$83.38K10,590IndirectHeld by the John Coghlan Living Trust
SaleNov 2, 2026
Common stockF1F31,433$46.00$65.92K9,157IndirectHeld by the John Coghlan Living Trust
SaleNov 2, 2026
Common stockF1F4726$46.69$33.90K8,431IndirectHeld by the John Coghlan Living Trust
Filing footnotes · 5
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.
  2. F2The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $44.52 to $45.51, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  3. F3The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $45.54 to $46.47, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  4. F4The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $46.54 to $46.75, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  5. F5Includes 3,630 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
Open on SEC EDGAR
Charles J. ProberDirector
4Rule 10b5-1 plan disclosed
Filed Oct 15, 2026Period of report Oct 13, 20260001581760-26-000171
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleOct 13, 2026
Common stockF1F27,930$43.29$343.29K109,930Direct
Filing footnotes · 3
  1. F1The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
  2. F2Includes 3,361 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  3. F3The stock option is fully vested and exercisable.
Open on SEC EDGAR
Alex HaroDirector
4Rule 10b5-1 plan disclosed
Filed Oct 8, 2026Period of report Oct 6, 20260001581760-26-000169
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleOct 6, 2026
Common stockF1F3F248,608$41.41$2.01M1,011,695Direct
SaleOct 6, 2026
Common stockF1F4F21,392$42.36$58.97K1,010,303Direct
Filing footnotes · 5
  1. F1The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2026. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
  2. F2Includes 3,342 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.137 to $42.135, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 3.
  4. F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.145 to $42.74, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 4.
  5. F5The stock option is fully vested and exercisable.
Open on SEC EDGAR
John Philip CoghlanDirector
4Rule 10b5-1 plan disclosed
Filed Oct 5, 2026Period of report Oct 1, 20260001581760-26-000167
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleOct 1, 2026
Common stockF1F23,800$40.34$153.29K12,631IndirectHeld by the John Coghlan Living Trust
SaleOct 1, 2026
Common stockF1F3200$40.97$8.19K12,431IndirectHeld by the John Coghlan Living Trust
Filing footnotes · 4
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.
  2. F2The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $39.86 to $40.82, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  3. F3The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $40.95 to $40.98, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  4. F4Includes 3,630 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
Open on SEC EDGAR
Alex HaroDirector
4Rule 10b5-1 plan disclosed
Filed Sep 23, 2026Period of report Sep 21, 20260001581760-26-000165
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleSep 21, 2026
Common stockF1F3F231,275$40.72$1.27M1,029,028Direct
SaleSep 21, 2026
Common stockF1F4F218,725$41.16$770.72K1,010,303Direct
Filing footnotes · 5
  1. F1The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2026. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
  2. F2Includes 3,342 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.04 to $41.02, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 3.
  4. F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.047 to $41.340, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 4.
  5. F5The stock option is fully vested and exercisable.
Open on SEC EDGAR
Charles J. ProberDirector
4Rule 10b5-1 plan disclosed
Filed Sep 16, 2026Period of report Sep 14, 20260001581760-26-000162
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleSep 14, 2026
Common stockF1F27,930$42.12$334.01K109,930Direct
Filing footnotes · 3
  1. F1The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
  2. F2Includes 3,361 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  3. F3The stock option is fully vested and exercisable.
Open on SEC EDGAR
John Philip CoghlanDirector
4Rule 10b5-1 plan disclosed
Filed Sep 3, 2026Period of report Sep 1, 20260001581760-26-000155
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleSep 1, 2026
Common stockF1F24,000$41.97$167.88K16,431IndirectHeld by the John Coghlan Living Trust
Filing footnotes · 3
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.
  2. F2The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $41.72 to $42.21 , inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  3. F3Includes 4,840 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
Open on SEC EDGAR
James SyngeDirector
4
Filed Aug 27, 2026Period of report Aug 25, 20260001581760-26-000153
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 26, 2026
Common stockF1F2F6F7F4F527,466$44.31$1.22M191,694Direct
SaleAug 25, 2026
Common stockF1F2F3F4F55,833$45.05$262.78K219,160Direct
Filing footnotes · 7
  1. F1The sale being reported on this Form 4 is the sale of Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs were traded on the Australian Securities Exchange (the "ASX") and were held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.
  2. F2Reflects the number of common stock equivalent shares underlying the CDIs sold on the ASX.
  3. F3Reflects the weighted average sale price of the CDIs sold, as converted to USD by multiplying the amount by 3, based on the 3:1 conversion ratio for CDIs to common stock, and then multiplying by the exchange rate of 0.715 in effect at the time of the sale as published by the Reserve Bank of Australia.
  4. F4Includes 4,600 RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  5. F5Includes common stock and the number of shares of common stock underlying CDIs as converted on a 1:3 common stock to CDI ratio.
  6. F6The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.169 to $44.557, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 3.
  7. F7Reflects the weighted average sale price of the CDIs sold, as converted to USD by multiplying the amount by 3, based on the 3:1 conversion ratio for CDIs to common stock, and then multiplying by the exchange rate of 0.7182 in effect at the time of the sale as published by the Reserve Bank of Australia.
Open on SEC EDGAR
Chris HullsDirector
4
Filed Aug 19, 2026Period of report Aug 18, 20260001581760-26-000148
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 18, 2026
Common StockF3F1F2231,434$46.78$10.83M400,622Direct
SaleAug 18, 2026
Common StockF4F1F218,566$47.58$883.37K382,056Direct
Filing footnotes · 6
  1. F1Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.
  2. F2Includes 134,496 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  3. F3The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $46.36 to $47.35, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  4. F4The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $47.36 to $48.30, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  5. F5Represents shares of the Issuer's common stock underlying 585,938 CDIs.
  6. F6The stock option is fully vested and exercisable.
Open on SEC EDGAR
Charles J. ProberDirector
4Rule 10b5-1 plan disclosed
Filed Aug 17, 2026Period of report Aug 13, 20260001581760-26-000146
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 13, 2026
Common stockF1F27,930$48.59$385.32K109,930Direct
Filing footnotes · 3
  1. F1The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
  2. F2Includes 4,474 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  3. F3The stock option is fully vested and exercisable.
Open on SEC EDGAR
Brit MorinDirector
4
Filed Aug 12, 2026Period of report Aug 10, 20260001581760-26-000144
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 10, 2026
Common stockF1F215,582$65.00$1.01M14,340Direct
Filing footnotes · 3
  1. F1The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
  2. F2Includes 4,636 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  3. F3The stock option is fully vested and exercisable.
Open on SEC EDGAR
Brit MorinDirector
4Rule 10b5-1 plan disclosed
Filed Aug 5, 2026Period of report Aug 4, 20260001581760-26-000135
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 4, 2026
Common stockF1F210,701$60.00$642.06K20,157Direct
Filing footnotes · 3
  1. F1The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
  2. F2Includes 4,636 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  3. F3The stock option is fully vested and exercisable.
Open on SEC EDGAR
Chris HullsDirector
4Rule 10b5-1 plan disclosed
Filed Aug 5, 2026Period of report Aug 4, 20260001581760-26-000133
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 4, 2026
Common StockF1F4F2F317,020$63.08$1.07M429,534Direct
SaleAug 4, 2026
Common StockF1F5F2F39,980$63.77$636.42K419,554Direct
Filing footnotes · 7
  1. F1The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
  2. F2Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.
  3. F3Includes 134,496 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  4. F4The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $62.50 to $63.49, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  5. F5The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $63.50 to $64.03, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  6. F6Represents shares of the Issuer's common stock underlying 585,938 CDIs.
  7. F7The stock option is fully vested and exercisable.
Open on SEC EDGAR
John Philip CoghlanDirector
4Rule 10b5-1 plan disclosed
Filed Aug 5, 2026Period of report Aug 3, 20260001581760-26-000131
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 3, 2026
Common stockF1F21,400$54.66$76.52K23,031IndirectHeld by the John Coghlan Living Trust
SaleAug 3, 2026
Common stockF1F32,600$54.90$142.74K20,431IndirectHeld by the John Coghlan Living Trust
Filing footnotes · 4
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.
  2. F2The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $53.83 to $54.80, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  3. F3The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $54.89 to $54.95, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  4. F4Includes 4,840 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
Open on SEC EDGAR
Chris HullsDirector
4Rule 10b5-1 plan disclosed
Filed Jul 20, 2026Period of report Jul 16, 20260001581760-26-000126
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 16, 2026
Common StockF1F4F2F314,345$55.74$799.59K419,554Direct
Filing footnotes · 6
  1. F1The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
  2. F2Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.
  3. F3Includes 134,496 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  4. F4The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $55.46 to $56.13, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  5. F5Represents shares of the Issuer's common stock underlying 585,938 CDIs.
  6. F6The stock option is fully vested and exercisable.
Open on SEC EDGAR
Charles J. ProberDirector
4Rule 10b5-1 plan disclosed
Filed Jul 15, 2026Period of report Jul 13, 20260001581760-26-000124
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 13, 2026
Common stockF1F27,930$53.05$420.69K109,911Direct
Filing footnotes · 3
  1. F1The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
  2. F2Includes 4,455 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  3. F3The stock option is fully vested and exercisable.
Open on SEC EDGAR
John Philip CoghlanDirector
4Rule 10b5-1 plan disclosed
Filed Jul 6, 2026Period of report Jul 1, 20260001581760-26-000122
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 1, 2026
Common stockF1F23,798$56.04$212.84K24,633IndirectHeld by the John Coghlan Living Trust
SaleJul 1, 2026
Common stockF1F3202$56.57$11.43K24,431IndirectHeld by the John Coghlan Living Trust
Filing footnotes · 4
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.
  2. F2The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $55.52 to $56.47, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  3. F3The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $56.52 to $56.67, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  4. F4Includes 4,840 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
Open on SEC EDGAR
Brit MorinDirector
4Rule 10b5-1 plan disclosed
Filed Jul 1, 2026Period of report Jun 29, 20260001581760-26-000120
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 29, 2026
Common stockF1F24,655$55.00$256.03K25,975Direct
Filing footnotes · 2
  1. F1The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
  2. F2Includes 4,636 RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
Open on SEC EDGAR
Chris HullsDirector
4Rule 10b5-1 plan disclosed
Filed Jun 23, 2026Period of report Jun 18, 20260001581760-26-000118
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 18, 2026
Common StockF1F4F2F316,042$47.07$755.10K406,899Direct
Filing footnotes · 6
  1. F1The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
  2. F2Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.
  3. F3Includes 134,496 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  4. F4The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $46.92 to $47.39, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  5. F5Represents shares of the Issuer's common stock underlying 585,938 CDIs.
  6. F6The stock option is fully vested and exercisable.
Open on SEC EDGAR
Charles J. ProberDirector
4Rule 10b5-1 plan disclosed
Filed Jun 17, 2026Period of report Jun 15, 20260001581760-26-000116
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 15, 2026
Common stockF1F27,930$46.07$365.34K109,911Direct
Filing footnotes · 3
  1. F1The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
  2. F2Includes 4,455 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  3. F3The stock option is fully vested and exercisable.
Open on SEC EDGAR
John Philip CoghlanDirector
4
Filed Jun 2, 2026Period of report May 29, 20260001581760-26-000091
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 1, 2026
Common stockF3F43,796$43.95$166.83K28,635IndirectHeld by the John Coghlan Living Trust
SaleJun 1, 2026
Common stockF3F5204$44.64$9.11K28,431IndirectHeld by the John Coghlan Living Trust
Filing footnotes · 5
  1. F1Represents the grant of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 1/4th of the RSUs will vest quarterly from May 15, 2026, subject to the Reporting Person's continuous service through each vest date.
  2. F2Includes 5,676 RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  3. F3This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.
  4. F4The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $43.53 to $44.52, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  5. F5The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $44.63 to $44.64, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
Open on SEC EDGAR
Chris HullsDirector
4Rule 10b5-1 plan disclosed
Filed Jun 1, 2026Period of report May 28, 20260001581760-26-000088
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 28, 2026
Common StockF1F4F2F316,379$40.34$660.73K403,485Direct
Filing footnotes · 6
  1. F1The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
  2. F2Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.
  3. F3Includes 149,318 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  4. F4The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $40.17 to $40.87, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  5. F5Represents shares of the Issuer's common stock underlying 585,938 CDIs.
  6. F6The stock option is fully vested and exercisable.
Open on SEC EDGAR
Charles J. ProberDirector
4Rule 10b5-1 plan disclosed
Filed May 15, 2026Period of report May 13, 20260001581760-26-000081
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 13, 2026
Common stockF1F27,930$40.44$320.69K105,456Direct
Filing footnotes · 3
  1. F1The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
  2. F2Includes 679 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  3. F3The stock option is fully vested and exercisable.
Open on SEC EDGAR
John Philip CoghlanDirector
4Rule 10b5-1 plan disclosed
Filed May 5, 2026Period of report May 1, 20260001581760-26-000073
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 1, 2026
Common stockF1F23,736$44.12$164.83K32,695IndirectHeld by the John Coghlan Living Trust
SaleMay 1, 2026
Common stockF1F3264$44.67$11.79K32,431IndirectHeld by the John Coghlan Living Trust
Filing footnotes · 4
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.
  2. F2The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $43.59 to $44.56, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  3. F3The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $44.59 to $44.70, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  4. F4Represents 836 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
Open on SEC EDGAR
Chris HullsDirector
4Rule 10b5-1 plan disclosed
Filed Apr 20, 2026Period of report Apr 16, 20260001581760-26-000071
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 16, 2026
Common StockF1F4F2F316,105$45.51$732.94K399,809Direct
Filing footnotes · 7
  1. F1The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
  2. F2Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.
  3. F3Includes 149,318 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  4. F4The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $45.36 to $46.11, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  5. F5This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units.
  6. F6Represents shares of the Issuer's common stock underlying 585,938 CDIs.
  7. F7The stock option is fully vested and exercisable.
Open on SEC EDGAR
Lauren AntonoffDirector · Chief Executive Officer
4
Filed Apr 20, 2026Period of report Apr 16, 20260001581760-26-000067
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 16, 2026
Common StockF1F22,716$45.231$122.85K309,781Direct
Filing footnotes · 2
  1. F1The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of previously reported restricted stock units ("RSUs"). The sale was to satisfy tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the Reporting Person.
  2. F2Includes 161,566 RSUs previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
Open on SEC EDGAR
Charles J. ProberDirector
4Rule 10b5-1 plan disclosed
Filed Apr 15, 2026Period of report Apr 13, 20260001581760-26-000055
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 13, 2026
Common stockF1F27,930$37.27$295.55K105,456Direct
Filing footnotes · 3
  1. F1The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
  2. F2Includes 679 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  3. F3The stock option is fully vested and exercisable.
Open on SEC EDGAR
John Philip CoghlanDirector
4Rule 10b5-1 plan disclosed
Filed Apr 3, 2026Period of report Apr 1, 20260001581760-26-000049
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 1, 2026
Common stockF1F2F34,000$41.32$165.28K36,431IndirectHeld by the John Coghlan Living Trust
Filing footnotes · 4
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.
  2. F2The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $41.13 to $41.53, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  3. F3The Reporting Person transferred 35,366 directly held shares to the John Coghlan Living Trust, which transfer was exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended (the "Exchange Act").
  4. F4Represents 836 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
Open on SEC EDGAR
Chris HullsDirector
4Rule 10b5-1 plan disclosed
Filed Mar 23, 2026Period of report Mar 19, 20260001581760-26-000038
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 19, 2026
Common StockF1F4F2F315,133$39.43$596.69K334,319Direct
Filing footnotes · 6
  1. F1The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
  2. F2Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.
  3. F3Includes 108,371 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  4. F4The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $39.23 to $39.71, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  5. F5Represents shares of the Issuer's common stock underlying 585,938 CDIs.
  6. F6The stock option is fully vested and exercisable.
Open on SEC EDGAR
David WiadrowskiDirector
4
Filed Mar 17, 2026Period of report Mar 13, 20260001581760-26-000033
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 13, 2026
Common StockF3F4F25,957$41.34$246.26K39,679Direct
Filing footnotes · 5
  1. F1The reporting person exercised the stock options on a cashless basis.
  2. F2Includes 738 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  3. F3Shares of the Issuer's common stock were sold in the open market solely to cover the option exercise cost.
  4. F4The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $41.27 to $41.455, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  5. F5The stock option is fully vested and exercisable.
Open on SEC EDGAR
Charles J. ProberDirector
4Rule 10b5-1 plan disclosed
Filed Mar 17, 2026Period of report Mar 13, 20260001581760-26-000031
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 13, 2026
Common stockF1F27,930$41.40$328.30K105,456Direct
Filing footnotes · 3
  1. F1The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
  2. F2Includes 679 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  3. F3The stock option vests and becomes exercisable as to 1/2 of the total number of shares on April 1, 2024 and thereafter vests and becomes exercisable as to 1/24th of the remaining shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date
Open on SEC EDGAR
John Philip CoghlanDirector
4Rule 10b5-1 plan disclosed
Filed Mar 11, 2026Period of report Mar 9, 20260001581760-26-000029
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 9, 2026
Common stockF1F21,242$45.29$56.25K7,823IndirectHeld by the John Coghlan Living Trust
SaleMar 9, 2026
Common stockF1F32,758$46.56$128.41K5,065IndirectHeld by the John Coghlan Living Trust
Filing footnotes · 4
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.
  2. F2The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $44.75 to $45.70, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  3. F3The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $45.95 to $46.85, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  4. F4Includes 836 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
Open on SEC EDGAR
Lauren AntonoffDirector · Chief Executive Officer
4
Filed Mar 10, 2026Period of report Mar 6, 20260001581760-26-000023
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 6, 2026
Common StockF1F217,153$44.86$769.48K288,232Direct
Filing footnotes · 2
  1. F1The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of previously reported restricted stock units ("RSUs"). The sale was to satisfy tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the Reporting Person.
  2. F2Includes 143,367 RSUs previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
Open on SEC EDGAR
Charles J. ProberDirector
4Rule 10b5-1 plan disclosed
Filed Feb 18, 2026Period of report Feb 13, 20260001581760-26-000008
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 13, 2026
Common stockF1F27,930$49.02$388.73K105,456Direct
Filing footnotes · 3
  1. F1The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
  2. F2Includes 1,357 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  3. F3The stock option vests and becomes exercisable as to 1/2 of the total number of shares on April 1, 2024 and thereafter vests and becomes exercisable as to 1/24th of the remaining shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.
Open on SEC EDGAR
Charles J. ProberDirector
4Rule 10b5-1 plan disclosed
Filed Jan 15, 2026Period of report Jan 13, 20260001581760-26-000002
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 13, 2026
Common stockF1F27,930$61.98$491.50K105,456Direct
Filing footnotes · 3
  1. F1The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
  2. F2Includes 1,357 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  3. F3The stock option vests and becomes exercisable as to 1/2 of the total number of shares on April 1, 2024 and thereafter vests and becomes exercisable as to 1/24th of the remaining shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.
Open on SEC EDGAR
Chris HullsDirector
4
Filed Dec 18, 2025Period of report Dec 16, 20250000905148-25-004433
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 16, 2025
Common StockF1F21,139$63.63$72.47K707IndirectHeld by ICCA Labs, LLC
SaleDec 16, 2025
Common StockF3F2707$64.49$45.59K0IndirectHeld by ICCA Labs, LLC
Filing footnotes · 6
  1. F1The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $63.36 to $64.33, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  2. F2The Reporting Person is a member of ICCA Labs, LLC, an entity that held an aggregate of 8,219 shares of the Issuer's common stock prior to the sales reported herein. The number of shares held as reported herein by the Reporting Person represents his proportionate ownership interest in ICCA Labs, LLC.
  3. F3The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $64.36 to $64.57, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  4. F4Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.
  5. F5Includes 122,667 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  6. F6Represents shares of the Issuer's common stock underlying 585,938 CDIs.
Open on SEC EDGAR
Alex HaroDirector
4
Filed Dec 18, 2025Period of report Dec 16, 20250000905148-25-004432
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 16, 2025
Common StockF1F21,165$63.63$74.13K722IndirectHeld by ICCA Labs, LLC
SaleDec 16, 2025
Common StockF3F2722$64.49$46.56K0IndirectHeld by ICCA Labs, LLC
Filing footnotes · 4
  1. F1The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $63.36 to $64.33, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  2. F2The Reporting Person is a member of ICCA Labs, LLC, an entity that held an aggregate of 8,219 shares of the Issuer's common stock prior to the sales reported herein. The number of shares held as reported herein by the Reporting Person represents his proportionate ownership interest in ICCA Labs, LLC.
  3. F3The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $64.36 to $64.57, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  4. F4Includes 1,357 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
Open on SEC EDGAR
James SyngeDirector
4
Filed Dec 18, 2025Period of report Dec 16, 20250000905148-25-004431
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 16, 2025
Common StockF1F22,448$63.63$155.77K1,518IndirectHeld by ICCA Labs, LLC
SaleDec 16, 2025
Common StockF3F21,518$64.49$97.90K0IndirectHeld by ICCA Labs, LLC
Filing footnotes · 5
  1. F1The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $63.36 to $64.33, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  2. F2The Reporting Person has shared investment control over Carthona Capital FS Pty Ltd. ("Carthona Capital"). Carthona Capital is a member of ICCA Labs, LLC, an entity that held an aggregate of 8,219 shares of the Issuer's common stock prior to the sales reported herein. The number of shares held as reported herein represents Carthona Capital's proportionate ownership interest in ICCA Labs, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
  3. F3The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $64.36 to $64.57, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  4. F4Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.
  5. F5Includes 1,405 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
Open on SEC EDGAR
Charles J. ProberDirector
4Rule 10b5-1 plan disclosed
Filed Dec 17, 2025Period of report Dec 15, 20250001581760-25-000245
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 15, 2025
Common stockF1F27,930$68.30$541.62K105,456Direct
Filing footnotes · 3
  1. F1The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
  2. F2Includes 1,357 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  3. F3The stock option vests and becomes exercisable as to 1/2 of the total number of shares on April 1, 2024 and thereafter vests and becomes exercisable as to 1/24th of the total number of shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.
Open on SEC EDGAR
John Philip CoghlanDirector
4Rule 10b5-1 plan disclosed
Filed Dec 9, 2025Period of report Dec 5, 20250000905148-25-004289
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 5, 2025
Common StockF1F2F32,025$76.82$155.56K13,210IndirectHeld by the John Coghlan Living Trust
SaleDec 5, 2025
Common StockF1F41,100$77.96$85.76K12,110IndirectHeld by the John Coghlan Living Trust
Filing footnotes · 6
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 6, 2024. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.
  2. F2The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $76.45 to $77.28, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  3. F3The Reporting Person transferred 3,045 shares indirectly held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust to the John Coghlan Living Trust, and transferred 3,045 shares indirectly held by the John Coghlan Living Trust to The John Philip Coghlan 2025 Grantor Retained Annuity Trust, which transfers were exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended.
  4. F4The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $77.52 to $78.41, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  5. F5This transaction reflects a bona fide gift of the Issuer's common stock to a donor-advised fund (DAF) for charitable purposes. The Reporting Person retains no beneficial ownership or control over the donated securities following the contribution.
  6. F6Includes 1,672 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
Open on SEC EDGAR
Lauren AntonoffDirector · Chief Executive Officer
4
Filed Dec 8, 2025Period of report Dec 4, 20250001581760-25-000239
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 4, 2025
Common StockF1F219,442$76.244$1.48M305,385Direct
Filing footnotes · 2
  1. F1The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of previously reported restricted stock units ("RSUs"). The sale was to satisfy tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the Reporting Person.
  2. F2Includes 183,374 RSUs previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
Open on SEC EDGAR
Mark GoinesDirector
4
Filed Dec 5, 2025Period of report Dec 3, 20250001581760-25-000233
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 3, 2025
Common stockF115,000$74.19$1.11M56,809IndirectHeld by the Goines Wong Living Trust
Filing footnotes · 2
  1. F1The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $74.13 to $74.46, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  2. F2Includes 2,339 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
Open on SEC EDGAR
Alex HaroDirector
4
Filed Dec 1, 2025Period of report Dec 1, 20250000905148-25-004206
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 1, 2025
Common StockF1F247,889$75.95$3.64M913,426Direct
SaleDec 1, 2025
Common StockF3F252,111$76.90$4.01M861,315Direct
Filing footnotes · 4
  1. F1The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $75.42 to $76.41, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  2. F2Includes 2,714 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  3. F3The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $76.42 to $77.37, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  4. F4The Reporting Person is a member of ICCA Labs, LLC, an entity that holds an aggregate of 8,219 shares of the Issuer's common stock. The number of shares held as reported herein by the Reporting Person represents his proportionate ownership interest in ICCA Labs, LLC.
Open on SEC EDGAR
Chris HullsDirector
4
Filed Nov 26, 2025Period of report Nov 25, 20250000905148-25-004189
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 26, 2025
Common StockF7F1F2100,465$78.62$7.90M354,948Direct
SaleNov 26, 2025
Common StockF8F1F219,535$79.11$1.55M335,413Direct
SaleNov 25, 2025
Common StockF3F1F2226,556$76.91$17.42M554,942Direct
SaleNov 25, 2025
Common StockF4F1F280,193$77.56$6.22M474,749Direct
SaleNov 25, 2025
Common StockF5F1F25,000$78.38$391.90K469,749Direct
Filing footnotes · 12
  1. F1Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.
  2. F10The Reporting Person is a member of ICCA Labs, LLC, an entity that holds an aggregate of 8,219 shares of the Issuer's common stock. The number of shares held as reported herein by the Reporting Person represents his proportionate ownership interest in ICCA Labs, LLC.
  3. F11The stock option is fully vested and exercisable.
  4. F12The stock option vests and becomes exercisable as to 1/48th of the total number of shares in equal monthly installments beginning on February 1, 2022, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
  5. F2Includes 137,853 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  6. F3The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $76.25 to $77.245, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  7. F4The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $77.25 to $78.21, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  8. F5The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $78.32 to $78.43, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  9. F6This transaction reflects a bona fide gift of the Issuer's stock to a donor-advised fund (DAF) for charitable purposes. The Reporting Person retains no beneficial ownership or control over the donated securities following the contribution.
  10. F7The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $78.02 to $79.015, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  11. F8The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $79.02 to $79.34, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  12. F9Represents shares of the Issuer's common stock underlying 585,938 CDIs.
Open on SEC EDGAR
Lauren AntonoffDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Nov 25, 2025Period of report Nov 24, 20250001581760-25-000231
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 24, 2025
Common StockF1F24,546$76.10$345.95K324,827Direct
Filing footnotes · 2
  1. F1The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2024. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
  2. F2Includes 222,277 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.